Olympia Snowe Quotes

I would say that the pharmaceutical industry is hyper-competitive from a global perspective.

The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors.

The goal of re-importation is to provide American consumers with access to drugs at the world market price - not the inflated price now paid only by Americans.

Reducing trade barriers with this key ally will go a long way toward increasing market access for American farmers, manufacturers and service providers.

Healthy competition places discipline on the market and should focus providers on providing the best service at a lower cost.

Drug manufacturers could afford to sell AIDS drugs in Africa at virtually any discount. The companies said they did not do so because Africa lacked the requisite infrastructure.

I've always considered making it legal for Americans to import their prescription drugs a free-trade issue. Imports create competition and keep domestic industry more responsive to consumers.

Since trade ignores national boundaries and the manufacturer insists on having the world as a market, the flag of his nation must follow him, and the doors of the nations which are closed against him must be battered down.

there are times when we need to step in to make sure that competition works the way it should. By doing that, we help the market to work fairly, because competition gives consumers the power to demand a fair deal. It means that companies know that if they cannot offer good prices or the service that's expected, well, the customers will go somewhere else.

Competition is the best way to ensure prescription drugs are affordable.

When prices are transparent and competition is encouraged, consumers win. We believe that can prove true in health care as it has in every other area of the American economy.

Trade wars in which countries are then obliged to retaliate by raising their own tariffs against the initiator undermine growth and hurt consumers. Far from being expressions of strength they highlight the failure of the initiating country's economic sector to compete in the global market place.

Competition is a powerful and essential part of this nation's economy and vital to cutting government costs.

We will throw the highways of commerce open on equal terms to all who use them.

Early consolidation of hospitals was for efficiency to reduce costs. However in local market's consolidations have become monopolies and have increased costs.

Markets, when left to themselves, can sort of slip into being just the private property of big businesses and cartels, meeting the needs of some businesses and not the needs of customers.

Competition is good for consumers. It provides more choices at better prices.

We can't just say the right thing on lowering the cost of prescription drugs: we have to do the right thing, too.

Both Republicans and Democrats can agree that more choices and lower prices in transportation would benefit consumers. Democrats would consider it 'smart government' and Republicans 'limited government.'

No one was talking about price decreases, but that does happen in the industry to keep medicine affordable.

Where there's a lack of competition - as we saw with Mylan Pharmaceutical's virtual monopoly on EpiPen - price increases often follow.

There has to be a drive to make the U.K. competitive in the motorcar industry or in the engineering industry. To do that, you have to give attention to the manufacturing sector.

It's not in my mission to work against Euroskepticism; it's my mission to work for fair markets. In antitrust, what is at stake is, in some ways, as old as Adam and Eve because it is about greed, to get more.

American businesses and consumers deserve a debit card system with competition, transparency, and reasonable fees.

To ensure that America remains the leader in medical innovation, we must reduce the costs of developing life-saving drugs and ensure that there are appropriate economic incentives in place to produce them.